coronavirus
cov
typic
affect
respiratori
tract
gut
mammal
bird
cov
belong
subfamili
coronavirina
famili
coronavirida
organ
four
genera
first
coronaviru
isol
avian
infecti
bronchiti
viru
ibv
today
serious
devast
poultri
stock
human
coronavirus
hcov
first
identifi
cultiv
nasal
caviti
patient
suffer
common
cold
approxim
common
cold
caus
two
human
particular
medic
interest
viru
respons
sever
actur
respiratori
syndrom
sar
produc
near
pandem
recent
emerg
middl
east
respiratori
syndrom
coronaviru
merscov
year
caus
hundr
death
current
effect
licens
treatment
exist
coronaviru
infect
although
live
vaccin
consist
attenu
virus
promis
strategi
along
fusion
inhibitor
review
howev
possibl
reappear
virul
phenotyp
drug
side
effect
resist
call
continu
antivir
develop
latter
depend
intim
knowledg
coronaviru
molecular
biolog
describ
extens
elsewher
increasingli
accessori
protein
review
coronaviru
envelop
e
protein
describ
detail
envelop
e
protein
short
polypeptid
amino
acid
encod
cov
subgenom
rna
either
monocistron
polycistron
mrna
cov
e
protein
present
low
concentr
virion
except
e
protein
ibv
cov
e
protein
found
abundantli
intern
membran
exampl
mhv
sarscov
e
protein
found
ergolgi
intermedi
compart
ergic
virion
assembl
like
viroporin
despit
small
size
cov
e
protein
found
critic
pathogenesi
earlier
studi
show
overexpress
e
protein
mhv
sarscov
induc
apoptosi
howev
cell
infect
recombin
sarscov
lack
e
genea
biolog
relev
found
increas
apoptosi
cell
cultur
wherea
administr
e
protein
tran
reduc
stress
respons
cell
infect
e
protein
antiapoptot
effect
observ
cell
subject
treatment
also
elicit
cell
stress
delet
e
protein
also
reduc
pathogen
mortal
anim
model
led
develop
live
vaccin
base
edelet
etrunc
virion
although
precis
caus
attenu
known
appear
contribut
differ
part
e
protein
encompass
cytoplasm
ctermin
tail
well
transmembran
tm
domain
see
figur
fact
sarscov
e
integr
tm
domain
preserv
channel
activ
shown
import
inflammasom
activ
elev
product
proinflammatori
latter
effect
abolish
introduct
channel
inactiv
mutat
ibv
e
protein
shown
play
role
secretori
pathway
alter
lumen
environ
rearrang
secretori
organel
lead
effici
traffick
virion
rearrang
host
cell
membran
eg
golgi
complex
observ
cov
infect
virion
appear
larg
vacuol
deriv
golgierg
membran
ibv
e
mutat
align
channelinact
mutat
sarscov
e
figur
arrow
result
decreas
golgi
disrupt
effect
could
restor
conserv
polar
substitut
ser
asn
gln
addit
mutant
ibv
e
tm
domain
replac
nonoligomer
tm
domain
vesicular
stomat
viru
glycoprotein
vsv
g
defect
releas
infecti
viru
particl
particl
appear
accumul
intracellularli
point
tm
domain
ibv
e
import
forward
traffick
cargo
plasma
membran
golgi
complex
effect
could
due
either
loss
channel
activ
loss
tm
domain
integr
subsequ
disrupt
proteinprotein
interact
although
channel
activ
mutant
disrupt
golgi
rearrang
measur
later
found
mutant
channelinact
suggest
possibl
link
channel
activ
golgi
rearrang
understand
viroporin
biolog
essenti
complement
cellular
vivo
studi
biophys
structur
studi
purifi
protein
although
structur
data
avail
cov
e
protein
sarscov
e
mer
e
ibv
e
shown
singl
tm
domain
figur
tm
domain
form
homopentamer
channel
poor
ion
select
topolog
e
protein
channel
subject
controversi
recent
studi
untag
sarscov
e
protein
infect
cell
produc
model
cytoplasm
ctermin
domain
lumen
nterminu
topolog
also
like
e
protein
structur
data
avail
cov
e
protein
sarscov
e
tm
domain
character
detail
lipid
membran
dpc
micel
model
face
lumen
channel
wherea
involv
helixhelix
interact
subunit
figur
b
mutat
residu
abolish
channel
activ
vitro
introduct
mutat
recombin
sarscov
result
vivo
attenu
mous
model
interestingli
revert
mutant
regain
fit
pathogen
recov
sequenc
identifi
acquir
mutat
e
protein
tm
domain
mutat
compens
cluster
along
helix
interfac
opposit
figur
b
synthet
peptid
correspond
e
protein
tm
domain
bear
revert
mutat
eg
regain
channel
activ
measur
black
lipid
membran
revert
mutant
also
recov
pentamer
integr
shown
analysi
oligomer
size
mutant
truncat
form
sarscov
e
protein
etr
ie
e
figur
assay
use
perfluorooctano
acid
polyacrylamid
gel
electrophoresi
pfonupag
system
preserv
nativ
oligomer
size
membran
protein
compar
wild
type
etr
wt
channelinact
mutant
caus
migrat
chang
e
pentamer
form
star
show
delay
speci
pentam
band
see
white
arrow
destabil
obviou
monomer
speci
observ
bottom
gel
black
arrow
howev
revert
mutant
exhibit
compact
pentam
low
molecular
weight
band
correspond
monom
figur
clearli
show
mutant
restor
pentam
stabil
along
concomit
channel
activ
fact
sediment
equilibrium
profil
two
revert
mutant
could
fit
monomerpentam
model
log
ka
respect
compar
wildtyp
etr
log
ka
mutant
could
examin
analyt
ultracentrifug
poor
solubl
overal
data
suggest
channel
activ
cytoplasm
tail
integr
requir
simultan
achiev
virul
ctermin
domain
e
protein
contain
total
conserv
prolin
residu
center
predict
motif
bcbm
figur
construct
etr
e
encompass
motif
studi
mix
sdsdpc
micel
figur
howev
enviro
motif
mostli
residu
addit
secondari
structur
full
length
sarscov
e
protein
lipid
bilay
almost
complet
consist
presenc
structur
part
protein
nevertheless
fragment
adopt
studi
synthet
peptid
synthet
peptid
inspir
domain
form
amyloid
fiber
discrep
may
point
exist
frustrat
structur
pois
conform
chang
sarscov
e
region
found
redirect
plasma
membran
protein
golgi
region
mutat
design
increas
propens
aaaa
mutant
disrupt
membran
local
inde
purifi
etr
bear
mutat
produc
ir
spectrum
slightli
less
howev
although
possibl
small
fraction
popul
bcbm
fold
structur
report
cellular
effect
caus
said
aaaa
mutant
could
equal
caus
disrupt
proteinprotein
interact
mediat
expos
cytoplasm
domain
proposit
frustrat
bcbm
reminisc
viral
intern
fusion
peptid
region
high
structur
plastic
eg
hing
region
fusion
protein
fusion
protein
influenza
hemagglutinin
vesicular
stomat
viru
vsv
gprotein
presynapt
snare
tm
domain
may
translat
conform
chang
extramembran
domain
local
bilay
stress
fusogen
tm
domain
snare
vsv
gprotein
invers
correl
helic
solut
consist
presenc
snare
viral
fusion
protein
tm
domain
residu
ie
v
glycin
bulki
w
f
tm
domain
ctermin
tail
cov
e
protein
high
abund
bulki
residu
potenti
destabil
conform
figur
red
underlin
propos
e
protein
may
particip
induc
membran
curvatur
scission
particl
although
fusionfiss
activ
cov
e
protein
never
demonstr
hypothes
could
due
lack
suitabl
vitro
assay
eg
involv
e
protein
examin
possibl
complement
structur
studi
target
e
protein
lipid
bilay
solut
solid
state
nmr
interact
cov
e
protein
long
report
contribut
local
virion
format
protein
abund
protein
compon
virion
respons
shape
addit
three
predict
tm
domain
larg
ctermin
extramembran
domain
residu
expos
cytoplasm
interior
virion
form
contact
ctermin
tail
e
protein
interact
take
place
ergolgi
intermedi
compart
ergic
bud
compart
host
cell
contact
like
import
particl
assembl
sinc
mm
interact
major
driver
viral
envelop
format
mutant
mhv
produc
revert
partial
duplic
gene
newli
creat
protein
lack
ctermin
cytoplasm
tail
result
suggest
common
role
new
e
protein
dispers
deaggreg
packag
structur
data
e
protein
limit
precis
mechan
take
place
known
recent
yeasttwo
hybrid
search
interact
partner
sarscov
e
use
ctermin
extramembran
domain
bait
produc
abund
data
although
signific
binder
explor
report
one
binder
protein
associ
lin
seven
part
complex
control
polar
tight
junction
format
epithelia
interact
found
involv
pdz
domain
last
four
ctermin
residu
sarscov
e
protein
motif
hydrophob
amino
acid
e
protein
hijack
ergic
golgi
region
consist
observ
alter
lung
epithelia
integr
pdz
post
synapt
densiti
protein
drosophila
disc
larg
tumor
suppressor
zonula
protein
domain
common
structur
domain
amino
acid
found
organ
pdz
domain
bind
ctermin
tail
protein
although
intern
bind
site
also
report
review
pdz
domaincontain
protein
nonredund
pdz
domain
recogn
human
proteom
abundantli
repres
interact
alter
cellular
pathway
latter
suggest
wider
implic
newli
found
interact
virus
could
har
alter
pathway
advantag
model
figur
sarscov
e
last
ctermin
residu
includ
propos
pdzbind
motif
truncat
howev
sdsdpc
micellar
system
secondari
structur
full
length
protein
could
estim
use
chemic
shift
indic
predomin
random
coil
structur
part
protein
addit
synthet
peptid
encompass
last
residu
also
adopt
random
coil
conform
whether
solut
presenc
lipid
zwitterion
membran
somewhat
surpris
sinc
pdzbind
motif
adopt
typic
conform
howev
latter
may
induc
bind
altern
conform
domain
context
full
length
protein
presenc
lipid
membran
may
differ
one
observ
micel
addit
bind
ctermin
peptid
pdz
domain
recogn
intern
peptid
fragment
eg
par
partit
defect
pdz
domain
bind
intern
peptid
fragment
adopt
extend
conform
anoth
exampl
interact
pdz
domain
intern
finger
nno
pdz
domain
therefor
pdzbind
domain
e
protein
may
restrict
ctermin
amino
acid
ctermin
pdzbind
motif
found
sarscov
e
protein
later
shown
determin
virul
infect
mice
virus
lack
domain
lower
immun
respons
latter
paper
anoth
yeasttwo
hybrid
campaign
use
ctermin
sarscov
e
domain
discov
anoth
binder
syntenin
latter
scaffold
protein
initi
signal
cascad
result
phosphoryl
activ
mitogenactiv
protein
kinas
lead
express
proinflammatori
cytokin
disrupt
pathway
may
clear
therapeut
implic
sinc
sarscovinfect
patient
exacerb
inflammatori
respons
lead
epitheli
endotheli
damag
edema
acut
respiratori
distress
syndrom
ard
howev
delet
cterminu
result
viru
high
pathogen
reason
discrep
clear
suggest
compensatori
mechan
unpredict
effect
truncat
length
local
e
protein
structur
thu
epitheli
integr
inflammatori
respons
appear
involv
pdzbind
domain
notic
sever
virus
eg
human
papillomaviru
influenza
found
enhanc
pathogenesi
protein
contain
pdz
bind
motif
review
suggest
particular
case
wide
use
viral
strategi
cov
e
protein
may
also
interact
endogen
channel
modul
function
advantag
viru
xenopu
oocyt
shown
coexpress
sar
cov
e
human
epitheli
sodium
transport
enac
decreas
amiloridesensit
current
activ
pkc
subsequ
decreas
enac
surfac
level
similar
direct
indirect
inhibitori
effect
endogen
channel
propos
patch
clamp
result
sarscov
etransfect
cell
ibv
e
interact
endogen
channel
snare
hypothes
explain
rearrang
golgi
complex
respons
express
ibv
e
although
involv
ibv
e
channel
rule
exampl
ion
homeostasi
golgi
could
affect
nah
exchang
critic
maintain
low
lumin
ph
interact
viroporin
golgi
channel
transport
larg
unexplor
viroporin
field
notabl
case
alreadi
report
exampl
oncogen
protein
papillomaviru
abl
bind
vo
subunit
lumenacidifi
vatpas
prevent
assembl
pump
lead
alkalin
golgi
lumen
human
respiratori
syncyti
viru
hrsv
envelop
pneumoviru
paramyxovirida
famili
hrsv
first
isol
chimpanze
respiratori
ill
later
found
human
viru
hrsv
lead
caus
bronchiol
pneumonia
infant
elderli
frequent
caus
hospit
infant
young
children
industri
countri
gener
popul
hospit
rate
similar
found
influenza
infect
develop
countri
rsv
signific
caus
death
global
estim
death
young
children
hrsv
third
import
caus
deadli
childhood
pneumonia
streptococcu
pneumonia
haemophilu
influenza
epitheli
cell
respiratori
tract
major
site
viru
replic
hrsv
infect
wide
varieti
human
anim
cell
fusion
f
protein
facilit
viral
entri
cell
membran
format
bundl
critic
step
target
vitro
eg
peptid
mimic
conserv
domain
rsvf
protein
peptid
base
finteract
rhoa
gtpase
dendrimerlik
molecul
organ
compound
approach
involv
gene
transfer
expos
viral
protein
cell
sirna
specif
viral
protein
vaccin
recent
design
base
stabil
rsvf
form
preserv
highli
antigen
site
prefus
state
yield
rsvspecif
neutral
antibodi
mice
macaqu
recent
vaccin
candid
base
extracellular
domain
ctermin
rsv
viroporin
small
hydrophob
sh
protein
report
prevent
nasopulmonari
infect
mice
caus
rsv
report
use
stapl
peptid
target
fusogen
fprotein
bundl
howev
despit
effort
new
fdaapprov
drug
yet
emerg
palivizumab
human
monoclon
antibodi
igg
direct
f
protein
moder
effect
combin
high
cost
limit
use
small
fraction
patient
worldwid
licens
drug
use
infect
individu
ribavirin
nucleosid
analog
efficaci
limit
natur
acquir
immun
rsv
neither
complet
durabl
recurr
infect
occur
frequent
first
three
year
life
therefor
low
immunoprotect
lack
suitabl
antivir
make
imper
search
new
drug
target
strategi
effect
treatment
hrsv
genom
transcrib
protein
includ
three
membran
protein
fusion
f
small
hydrophob
sh
attach
g
play
role
initi
interact
viru
cell
small
hydrophob
sh
protein
rsv
subgroup
rsv
subgroup
b
amino
acid
long
singl
tm
domain
b
subgroup
capabl
induc
sever
lower
respiratori
tract
diseas
human
sh
protein
accumul
membran
golgi
complex
infect
cell
also
detect
endoplasm
reticulum
plasma
membran
rsv
lack
sh
still
viabl
still
form
syncytia
attenu
vivo
mous
rsv
replic
less
effici
upper
respiratori
tract
wherea
chimpanze
develop
significantli
less
rhinorrhea
infect
wildtyp
rsv
report
shown
lack
sh
protein
lead
attenu
phenotyp
children
rat
overal
result
indic
involv
hrsv
sh
protein
replic
pathogenesi
fact
recombin
rsv
delet
sh
gene
propos
live
vaccin
calv
human
common
sarscov
e
protein
sh
protein
block
delay
apoptosi
infect
cell
similar
antiapoptot
effect
sh
protein
observ
member
paramyxovirida
famili
encod
sh
protein
eg
j
paramyxoviru
jpv
mump
viru
muv
parainfluenza
viru
formerli
known
simian
viru
system
sh
protein
seem
block
apoptosi
infect
inhibit
pathway
exampl
apoptosi
induc
block
neutral
antibodi
receptor
antibodi
addit
sh
protein
gene
substitut
sh
protein
muv
rsv
strain
apoptosi
prevent
blockag
pathway
suggest
sh
protein
target
similar
pathway
unknown
mechan
delay
apoptosi
viru
may
evad
prematur
death
host
cell
allow
viral
replic
virus
abl
activ
inflammasom
activ
produc
proinflammatori
cytokin
eg
disrupt
ion
homeostasi
express
viroporin
allow
ion
leakag
intracellular
organel
cytosol
exampl
influenza
viru
iav
activ
result
h
ion
flux
golgi
mediat
ion
channel
protein
sever
picornavirus
includ
encephalomyocard
viru
emcv
polioviru
enteroviru
shown
induc
cytoplasm
reloc
inflammasom
activ
intracellular
manner
channel
activ
sarscov
e
protein
requir
process
requir
activ
channel
activ
sh
protein
may
also
result
directli
indirectli
activ
inflammasom
result
consist
report
hrsv
infect
led
cleavag
proinflammatori
cytokin
produc
caus
lung
patholog
diseas
exacerb
hrsv
mutant
led
reduc
secret
express
wherea
lipid
raft
disruptor
may
affect
sh
protein
target
golgi
lipid
raft
block
inflammasom
activ
similar
effect
observ
block
sh
protein
channel
activ
howev
drug
use
specif
particularli
effect
therefor
although
suggest
made
link
inflammasom
activ
sh
protein
channel
activ
ion
leakag
golgi
infect
confirm
topolog
rsv
sh
protein
opposit
cov
e
protein
n
ctermin
extramembran
domain
orient
cytoplasm
lumenallyextracellularli
respect
mutual
orient
transmembran
tm
form
ion
channel
determin
lipid
bilay
use
site
specif
infrar
dichroism
descript
full
length
sh
protein
monom
obtain
solut
nmr
dodecylphosphocholin
dpc
micel
bicel
like
sarscov
e
sh
protein
form
homopentamer
channel
low
ion
select
tm
domain
sh
protein
funnellik
architectur
figur
observ
viroporin
eg
influenza
sar
e
protein
hcv
narrow
region
tm
domain
line
hydrophob
side
chain
wherea
open
ntermin
region
line
polar
residu
ie
figur
rsv
sh
protein
tm
extend
ctermin
region
follow
loop
wherea
ntermin
cytoplasm
extramembran
domain
form
short
residu
figur
present
micel
bicel
sever
indic
suggest
involv
expos
cytoplasm
ntermin
tail
observ
antiapoptot
effect
sh
protein
see
exampl
addit
hemagglutinin
antigen
epitop
tag
cytoplasm
tail
sh
protein
abolish
abil
inhibit
signal
second
sh
protein
rsv
muv
human
pathogen
opposit
topolog
share
high
degre
similar
stretch
cytoplasm
domain
nterminu
rsv
sh
cterminu
muv
sh
figur
third
sh
protein
muv
jpv
extrem
short
lumen
domain
residu
respect
compar
much
longer
cytoplasm
domain
final
hrsv
sh
protein
sequenc
conserv
ntermin
cytoplasm
domain
interact
rsv
sh
g
protein
report
previous
infect
cell
although
signific
yet
clear
f
protein
seem
main
determin
host
cell
specif
viru
entri
f
g
protein
abl
bind
heparin
sulfat
put
cell
receptor
rsv
howev
tricompon
complex
sh
g
f
protein
observ
g
f
protein
one
predict
tm
domain
interact
sh
protein
tm
domain
extramembran
domain
latter
recent
membranebas
yeast
twohybrid
system
use
identifi
cellular
bind
partner
hrsv
sh
protein
bcell
receptorassoci
protein
human
lung
cdna
librari
membran
protein
locat
endoplasm
reticulum
er
essenti
role
sort
newli
synthes
membran
protein
addit
cytoplasm
cterminu
form
two
coil
coil
one
contain
variant
death
effector
domain
vded
flank
two
cleavag
site
domain
excis
upon
activ
produc
fragment
known
function
proapoptot
factor
also
form
complex
mitochondri
fission
membran
protein
span
er
mitochondria
serv
platform
activ
consequ
biolog
relev
interact
sh
protein
known
contact
may
interfer
interact
eg
sh
protein
bind
vded
domain
could
turn
prevent
cleavag
format
proapoptot
thu
delay
apoptosi
figur
screen
sh
protein
binder
refer
use
truncat
form
sh
protein
encompass
tm
domain
cytoplasm
domain
therefor
domain
involv
interact
latter
report
stretch
residu
ntermin
cytoplasm
helix
sh
protein
perturb
addit
vded
domain
full
length
sh
protein
micel
major
shift
observ
residu
figur
although
conserv
region
hrsv
sh
mump
viru
sh
protein
figur
residu
indic
conserv
wherea
sh
protein
show
homolog
region
suggest
latter
bind
differ
bind
site
system
intrigu
similar
rsv
sh
protein
found
human
papillomaviru
type
inde
apoptosi
induc
fa
ligand
fasl
tumor
necrosi
factorrel
apoptosisinduc
ligand
trail
strongli
suppress
keratinocyt
express
viroporin
also
found
bind
impair
format
deathinduc
signal
complex
trigger
trail
show
inhibit
ligandmedi
apoptosi
human
keratinocyt
primari
function
protein
mechan
inhibit
signal
sh
protein
clear
model
propos
sh
protein
interact
directli
indirectli
block
signal
prevent
produc
elucid
mechan
import
identifi
rsv
shinteract
protein
may
involv
apoptot
pathway
addit
unequivoc
link
sh
protein
ion
channel
activ
inflammasom
activ
channel
inact
mutant
need
test
obviou
candid
polar
residu
face
lumen
channel
figur
eg
mutat
mutant
disrupt
channel
structur
ie
obtain
introduc
bulki
side
chain
residu
involv
tm
helixhelix
interact
despit
fact
precis
mechan
link
viroporin
e
sh
delay
apoptosi
trigger
inflammasom
known
clear
novel
strategi
combat
viral
infect
alreadi
hypothes
exampl
model
shown
figur
confirm
one
envisag
possibl
stapl
peptid
mimick
cytoplasm
domain
sh
protein
disrupt
interact
shvded
lead
enhanc
apoptosi
cell
death
stapl
peptid
two
special
amino
acid
bear
olefin
side
chain
prior
final
fmocdeprotect
step
peptideresin
subject
ringclos
olefin
metathesi
ie
stapl
increas
peptid
stabil
helic
principl
membran
extramembran
part
protein
target
shown
recent
halobacterium
salinarium
efflux
small
multidrug
resist
protein
inhibit
peptid
target
tm
domain
case
peptid
disrupt
monomermonom
interact
viroporin
henc
abolish
channel
activ
still
unexplor
defin
interact
sarscov
e
protein
ctermin
tail
cellular
viral
binder
eg
e
similar
strategi
could
follow
design
peptid
mimic
cytoplasm
expos
domain
ctermin
tail
cov
e
protein
figur
conclud
sarscov
e
rsv
sh
viroporin
delay
apoptosi
infect
cell
may
help
evad
host
inflammatori
respons
prematur
death
host
cell
effect
may
relat
common
cytoplasm
orient
membranebound
connect
tm
domain
flexibl
loop
becom
appar
cytoplasm
orient
becom
templat
design
stapl
peptid
would
disrupt
proteinprotein
interact
viral
host
protein
interact
potenti
constitut
novel
drug
target
combat
viral
infect
howev
detail
mechanist
inform
avail
strategi
wide
use
